Uncategorized

An estimated eighty percent of people with coronary artery disease have cholesterol levels that fall within normal ranges. This suggests that standard cholesterol tests established over fifty years ago do not adequately identify a significant number of people at risk for heart attacks -- people who, if alerted, could take lifestyle and treatment steps to reduce their … [Read more...] about A Better Test for Heart Attack Risk

Lygos, a start-up biotechnology company founded based on technologies catalyzed by the DOE Office of Science through the Berkeley Lab-led Joint BioEnergy Institute (JBEI), discovered a new, environmentally-benign way to manufacture malonic acid using synthetic biology. In less than four years from this initial discovery, the startup, working with experts at Berkeley Lab's … [Read more...] about High Value Chemicals from Low Cost Sources

The Compact Dynamic Beamstop developed at Lawrence Berkeley National Laboratory (LBNL) and licensed exclusively by MiTeGen, LLC enhances protein crystallography research that supports development of treatments for diseases such as cancer, AIDS, Ebola, tuberculosis. In protein crystallography research, scientists use intense X-rays to extract structural and biological … [Read more...] about Tiny Tool for Life-Saving Research